Canine atopic dermatitis a look at current treatments
DOI:
https://doi.org/10.33448/rsd-v11i11.32807Keywords:
Dermatology; Allergy; Canine atopic dermatitis.Abstract
Canine Atopic Dermatitis is a chronic, inflammatory and pruritic skin condition, which is affected by several factors, which may be associated with genetic predisposition and changes in the epidermal barrier and which have a prevalence between 10% of the canine population, being the second most frequent allergic disease. The therapeutic approach takes into account several factors, such as seasonality, distribution and amount of affected skin, in addition to the severity of the lesion and stage of the disease, the patient's conditions, which can be topical or systemic, with a multimodal focus that includes the use of antipruritic drugs, allergen-specific immunotherapy and drugs that cause restructure the skin barrier and its microbiota. To highlight the current therapeutic alternatives for CAD. This is a literature review study, carried out in Pubmed, Scielo, Lilacs and Bireme databases with the keywords: Dermatology; Allergy; Canine Atopic Dermatitis. Therapeutic management of CAD is multifaceted and interventions should preferably be combined. The veterinarian must also remember that after evaluating, he must inform and discuss with the animal's owner about the possibilities and therapeutic choice so that he understands the benefit of each recommended intervention and whether the modality will be single or combined. Polytherapy and the use of drugs with fewer harmful side effects to the animal are recommended. Use protocols that help to restore the skin barrier and avoid allergens, as well as consider the cost of drugs and the financial conditions of the owner.
References
Arruda, L. K, Moreno, A. S, & Ferreira, F. (2013). Diagnóstico molecular de alergia: pronto para a prática clínica. Braz J Allergy Immunol. 1(4):187-194.
Bizikova, P., Santoro, D., Marsella, R., Nuttall, T., Eisenschenk, M. N.C., & Pucheu-Haston, C.M. (2015). Review: Clinical and histological manifestations of canine atopic dermatitis. Veterinary Dermatology. 26(2): 79-e24.
Bringel, F. A. (2011). Avaliação morfofuncional de pele humana conservada em glicerol e submetida à radiação gama: estudo em camundongos atímicos. 122 f. Tese (Doutorado em Ciências) – Instituto de Pesquisa Energética e Nucleares, Universidade de São Paulo.
Camões, A. F. B. (2021). Protocolo terapêutico alternativo com oclacitinib para dermatite atópica canina: uma solução capaz de reduzir custos? 54 f. Dissertação (Mestrado Integrado em Medicina Veterinária) - Universidade de Lisboa, Faculdade de Medicina Veterinária.
Campos, M. L., Silva, L. C., & Moraes-FILHO, J. (2021). Novos conceitos na dermatite atópica em cães – revisão de literatura. Brazilian Journal of Development, Curitiba, 7(6):54982-54994.
Collard, W. T., Hummel, B.D., Fielder, A.F., King, V.L., Boucher, J.F., Mullins, M.A., Malpas, P.B., & Stegemann, M.R. (2013). The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog. Journal Of Veterinary Pharmacology and Therapeutics. 37(3):279-285.
Cork, M. J., Danby, S.G., Vasilopoulos, Y., Hadgraft, J., Lane, M.E., Moustafa, M., Guy, R.H., Macgowan, A.L., Tazi-Ahnini, R., & Ward, S.J. (2019). Epidermal Barrier Dysfunction in Canine Atopic Dermatitis. Journal of Investigative Dermatology. 129(8):1892-1908.
Correa, M. L., & Val, A. P. C. (2018). Uso da acupuntura para controle do prurido de pequenos animais. Medvep Dermato - Revista de Educação Continuada em Dermatologia e Alergologia Veterinária. 5(14):60-64.
Cosgrove, S. B., Wren, J.A., Cleaver, D.M., Martin, D.D., Walsh, K.F, Harfst, J.A., Follis, S.L., King, V.L., Boucher, J.F., & Stegemann, M.R. (2013). Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Veterinary Dermatology. 24(5):479-e114.
Cosgrove, S.B.; Cleaver, D.M; King, V.L., Gilmer, A.R., Daniels, A.E., Wren, J.A., & Stegemann, M.R. (2015). Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Veterinary Dermatology. 26(3):171-179.
De Assunção, D. L, Cerdeiro, A. P. S, Ganho, R. G, & Silva, A. L. P. (2016). Suplementação com ácidos graxos poliinsaturados ômega-3 e ômega-6 no controle da dermatite atópica canina. Medvep Dermato - Revista de Educação Continuada em Dermatologia e Alergologia Veterinária. 4(12); 1-XXX.
Deboer, D. J., & Griffin, C.E. (2001). The ACVD task force on canine atopic dermatitis: antihistamine pharmacotherapy. Veterinary Imunology and Immunopathology, 81:323-329.
Dethioux, F. (2006). A dermatite atópica canina, um desafio para o clínico. Focus. 5-53.
Domingues, C. A. F. (2011). Abordagem clínica da alopecia no cão. 103 f. Dissertação (Mestrado Integrado em Medicina Veterinária) – Universidade de Trás-os-Montes e Alto Douro, Vila Real.
Figueiredo, K. B. W., Pereira, J. A., Wajczyk, T., Kaiser, D.L.G., Pereira, T.K. (2020). Insucessos e complicações no tratamento de dermatite atópica canina em Poodle: relato de caso (2012-2019). Pubvet. 14(5):1-7.
Frezza, A. P. D. M. (2019). Avaliação da soroprevalência aos alérgenos Der f 2 e Zen 1 do ácaro Dermatophagoides farinae em cães com dermatite atópica. 133 f. Dissertação (Mestrado em Faculdade de Medicina Veterinária e Zootecnia) - Universidade Estadual “Júlio de Mesquita Filho”.
Harvey, N.D., Stephen, C., Shaw, P. J., Craigon, S.C., & Blott, G.C.W. E. (2019). Environmental risk factors for canine atopic dermatitis: a retrospective large-scale study in Labrador and golden retrievers. Veterinary Dermatology. 30:396-e119.
Hensel, P., Hensel, P., Santoro, D., Favrot, C., Hill, P., &Griffin, C. (2015). Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Veterinary Research. 11:196.
Hill, P. (2007). Treatment of canine atopic dermatitis: balancing the three factors. In Pratice 29:566-573.
Hnilica, K. A.; Patterson, A. P. (2017). Small Animal Dermatology: A Color Atlas and Therapeutic Guide. 4. ed. Saint Louis: Elsevier, 633 p.
Kasutani, K., Fujii, E., Ohyama, S., Adachi, H., Hasegawa, M., Kitamura, H., & Yamashita, N. (2014). Anti-IL-31 receptor antibody is shown to be a potencial therapeutic option for treating itch and dermatitis in mice. British Journal of Pharmacology. 171(22): 5049-5058.
Linek, M.; Favrot, C. (2020). Impact of canine atopic dermatitis on the health-related quality of life of affected dogs and quality of life of their owners. Veterinary Dermatology. 21(15):456-462.
Larsson, C. E., & Lucas, R. (2016). Tratado de medicina externa: dermatologia veterinária. São Caetano do Sul: Interbook.
Lucas, R. (2007). Diagnóstico Diferencial das principais dermatopatias alérgicas. Revista nosso clínico. Ano 10, 55:6-18.
Madureira, R., & Brum, J. S. (2017). Diagnóstico dermatológico em pequenos animais: o que pode influenciar. Archives of Veterinary Science. 22(4).
Marsella, R. (2012). An update on the treatment of canine atopic dermatitis. Veterinary Medicine: Research and Reports.03:85-91.
Marsella, R., & Olivry, T. (2001). The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflamatory pharmacotherapy. Veterinary Imunology and Immunopathology. 81:311-345.
Martins, G. C. (2018). Análise de biomarcadores na dermatite atópica em cães antes e durante o tratamento com maleato de oclacitinib. 116 f. Tese (doutorado) – Universidade Federal de Minas Gerais. Escola de Veterinária.
Medeiros, V. B. (2017). Dermatite canina atópica. Journal of Surgical Research. 8:106-117.
Medleau, L., & Hnilica, A. K. (2003). Dermatologia de pequenos animais. Atlas colorido e guia terapêutico. 4 ed. GEN Guanabara Koogan, 656 p.
Michels, G.M., Ramsey, D.S., Walsh, K.F., Martinon, O.M., Mahabir, S.P., Hoevers, J.D., Walters, R.R., & Dunham, S.A. (2016). A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis. Vet Dermatol. 27(6):478-e129.
Miller, W., Griffin, C. E., & Campbell, K. L. (2013). Muller's & Kirk's: Small Animal Dermatology. 7. ed. Saint Louis: Elsevier, 948 p.
Moyaert, H., Van Brussel, L., Borowski, S., Escalada, M., Mahabir, S.P., Walters, R.R., & Stegemann, M.R. (2017). A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis. Vet Dermatol. 28(6):593-e145.
Souza Neto, A.; Farias, M. R. de; Pimpão, C. T.; Quitzan, J. G.; & Anater, A. (2017). Eficácia da ciclosporina no controle da dermatite atópica em cães. Pesq. Vet. Bras. 37(7):729-733.
Nuttall, T. (2008). Abordagem da dermatite atópica. Veterinary focus: dermatologia canina e felina. 18, 32-39.
Olivry, T., &Banovic, F. (2019). Treatment of canine atopic dermatitis: time to revise our strategy? Vet Dermatol. 30(2): 87-90.
Olivry, T., DeBoer, D.J., Favrot, C., Jackson, H.A., Mueller, R.S., Nuttall, T., & Prélaud, P. (2010). Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Veterinary Dermatology, 21:233-248.
Olivry, T. (2015). Tratamento da dermatite atópica canina: 2015 diretrizes atualizadas do Comitê Internacional de Doenças Alérgicas de Animais (ICADA). Veterinário BMC. Rev. 11:210.
Papich, M. G. (2016). Saunders Handbook of Veterinary Drugs: Small and Large Animal. 4. ed. Saint Louis: Elsevier, 1056 p.
Palmeiro, B. S., (2013). Cyclosporine in Veterinary Dermatology. Veterinary Clinical Small Animal, 43:153-171.
Paterson, S. (2008). Introduction: structure and function. In: Paterson, S. Manual of Skin Diseases of the Dog and Cat. 2.ed. Oxford: Blackwell Publishing, 364 p.
Pol, G., & Brazis, P. (2007). Alergenos mais frequentes da dermatite atópica canina. Veterinary Medicine International, 16-19.
Robayo, M., Ángel, M., & Robayo C. (2011). Acupuntura na dermatite atópica e mecanismos neuroimunológicos. Atualização. Revista da Faculdade de Medicina da Universidade Nacional da Colombia, 19:1.
Rodrigues, C. P. (2022). Medicina veterinária integrativa no tratamento da dermatite atópica canina (DAC): acupuntura, ozônioterapia, homeopatia e fitoterapia. Trabalho de Conclusão de Curso (Graduação em Medicina Veterinária. Universidade Estadual Paulista, Faculdade de Medicina Veterinária e Zootecnia) - Botucatu.
Rondelli, M. C. H., Palacios Junior, R. J.G., Oliveira, F. E., & Costa, M.T. (2015). Estudo retrospectivo da resposta clínica de cães atópicos a diferentes protocolos terapêuticos. Investigação, 14(2), 45–50.
Santoro, D. (2019). Terapias em Dermatite Atópica Canina: Uma Atualização. Veterinario. Clin. N. Am. Pequeno Anim. Pratique. 49, 9-26.
Silva, M. A. B. M. (2019). Avaliação do uso de lokivetmab (cytopoint) na dermatite atópica canina. 69 f. Dissertação apresentada à faculdade de Medicina Veterinária de Lisboa.
Solomon, S. E. B.; De Farias, M. R.; & Pimpão, C. T. (2012). Dermatite atópica canina: fisiopatologia e diagnóstico Canine atopic dermatitis: physiopathology and diagnosis. Revista Acadêmica Ciência Animal, 10(1):21-28.
Souza, C. P., Rosychuk, R.A.W., Contreras, E.T., Schissler, J.R., & Simpson, A.C. (2018). A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Veterinary Dermatology, 29(6): 489.
Suchodolski, J. S., Markel, M.E., & Garcia-Mazcorro, J.F. (2012). The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. Plos One. 7(12).
Tamamoto-Mochizuki, C., Paps, J. S., & Olivry, T. (2019). Proactive maintenance therapy of canine atopic dermatitis with the anti-IL-31 lokivetmab. Can a monoclonal antibody blocking a single cytokine prevent allergy flares. Veterinary Dermatology, 30(2): 98.
Thijs, J. L., Strickland, I., Bruijnzeel-Koomen, C.A.F.M., Nierkens, S., Giovannone, B., Knol, E.F., Csomor, E., Sellman, B.R., Mustelin, T., Sleeman, M, A, de Bruin-Weller, M.S., Herath, A., Drylewicz, J., May, R.D., & Hijnen, D. (2018). Serum biomarker profiles suggests that atopic dermatitis is a systemic disease. Journal of Allergy and Clinical Immunology. 141(4): 1523-1526.
Tilley, L., & Smith, F. W. K. (2016). Blackwell’s Five-Minute Veterinary Consult: Canine and Feline. 6. ed. Ames: John Wiley & Sons, 1.696 p.
Xie, H.; & Preast, V. (2006). Xie's Veterinary acupuncture. Iowa: Blackwell Publishing, 392 p.
Wang, A. X.; & Landén, N. X. (2015). New insights into T cells and their signature cytokines in atopic dermatitis. Biochem. Mol. Biol. Int., 67:601-610.
Watanabe, S., Narisawa, Y., Arase, S., Okamatsu, H., Ikenaga, T, Tajiri, Y., & Kumemura, M. (2003). Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 111(3):587-91.
Weidinger, S.; Beck, L. A.; Bieber, T.; Kabashima, K.; & Irvine, A. D. (2018). Atopic Dermatitis. Nature Reviews Disease Primers. 4:1-20.
Zanon, J. P., Gomes, L.A.; Cury, G.M.M.; Teles, T.C.; & Val Bicalho, A.P.C. (2008). Dermatite atópica canina. Semina: Ciências Agrárias. 29:4905-919.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Reinaldo Anderson Sanabri; Rodrigo Martins Ribeiro; Debora da Silva Freitas Ribeiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
